Collateral and Capillary Formation — A Comparison

  • E. Deindl
  • W. Schaper
Conference paper
Part of the Ernst Schering Research Foundation Workshop 28 book series (SCHERING FOUND, volume 28)


Vascular occlusive diseases are the major cause of mortality in Western civilization. The devastating consequences of ischemia and infarction could be prevented by the timely induction of collateral artery growth. Knowing the molecular mechanisms responsible for vessel growth is the basic requirement for the development of effective therapies.


Vascular Endothelial Growth Factor Plasminogen Activator Fibroblast Growth Factor Receptor Basic Fibroblast Growth Factor Collateral Artery 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham JA, Mergia A, Whang JL, Tumola A, Gospodarowicz D, Fiddes JC (1986) Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233:545–548PubMedCrossRefGoogle Scholar
  2. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W (1998) Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 101(l):4O-50Google Scholar
  3. Astrup T, Permin PM (1947) Fibrinolysis of the animal organism. Nature 159:681–682PubMedCrossRefGoogle Scholar
  4. Baird A, Klagsbrunn M (1991) The fibroblast growth factor family. Cancer Cells 3(6):239–243PubMedGoogle Scholar
  5. Basilico C, Moscatelli D (1992) The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115–165PubMedCrossRefGoogle Scholar
  6. Belin D, Godeau F, Vassilli JD (1984) Tumor promoter PMA stimulates the synthesis and secretion of mouse pro-urokinase in MSV-transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content. EMBO J 3(8):1901–1906PubMedGoogle Scholar
  7. Burgess WH, Maciag T (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575–606PubMedCrossRefGoogle Scholar
  8. Buschmann I, Ito W, Höfer I, Weiß G, Kostin S, Schaper J, Schaper W (1998) GM-CSF promotes collateral artery growth via prolongation of macrophage survival. J Mol Cell Cardiol 30:A126 (abstract)Google Scholar
  9. Clauss M, Weich H, Breier G, Knies U, Roeckl W, Waltenberg J, Risau W (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. J Biol Chem 271:17629–17634PubMedCrossRefGoogle Scholar
  10. Deindl E, Ito W, Zimmermann R, Schaper W (1997) Increased FGFR1 expression is a prerequisite for angiogenesis and collateral growth. J Mol Med 75(5): 13 (abstract)Google Scholar
  11. Deindl E, Ito W, Zimmermann RJ, Schaper W (1998) VEGF, in important angiogenic factor, is not involved in arteriogenesis. J Mol Med 76(6):B24 (abstract)Google Scholar
  12. Elenius K, Maatta A, Salmivirta M, Jalkanen M (1992) Growth factors induce 3T3 cells to express bFGF-binding syndecan. J Biol Chem 267(9):6435–6441PubMedGoogle Scholar
  13. Fernig DG, Gallagher JT (1994) Fibroblast growth factors and their receptors: an information network controlling tissue growth, morphogenesis and repair. Prog Growth Factor Res 5:353–377PubMedCrossRefGoogle Scholar
  14. Florkiewicz RZ, Sommer D (1989) Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons. Proc Natl Acad Sci USA 86:3978–3981PubMedCrossRefGoogle Scholar
  15. Folkman J (1995) Tumor angiogenesis. Saunders, PhiladelphiaGoogle Scholar
  16. Folkman J, D’Amore PA (1996) Blood vessel formation: what is its molecular basis. Cell 87:1153–1155PubMedCrossRefGoogle Scholar
  17. Givol D, Yayon A (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB 6:3362–3369Google Scholar
  18. Gorge G, Schmidt T, Ito BR, Pantely G, Schaper W (1988) Microvascular and collateral adaptation in swine hearts following progressive coronary artery stenosis. Basic Res Cardiol 84:524–535CrossRefGoogle Scholar
  19. Gross JL, Moscatelli D, Jaffe EA, Rifkin DB (1982) Plasminogen activator and collagenase production by cultured capillary endothelial cells. J Cell Biol 95:974–981PubMedCrossRefGoogle Scholar
  20. Hanahan D (1997) Signaling vascular morphogenesis and maintenance. Science 277:48–50PubMedCrossRefGoogle Scholar
  21. Ikeda E, Achen MG, Breier G, Risau W (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270:19761–19766PubMedCrossRefGoogle Scholar
  22. Isner JM, Piezcek A, Schainfeld R, Blair R, Haley L, Asahara T, Rosenfield K, Razvi S, Walsh K, Symes JF (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348:370–374PubMedCrossRefGoogle Scholar
  23. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W (1997) Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 80:829–837PubMedCrossRefGoogle Scholar
  24. Jackson RL, Busch S J, Cardin AD (1991) Glycosaminoglycans molecular properties protein interactions and role in physiological processes. Physiol Rev 71:481–540PubMedGoogle Scholar
  25. Jin Y, Pasumarthi BS, Bock ME, Lytras A, Kardami E, Cattini PA (1994) Cloning and expression of fibroblast growth factor receptor-1 isoforms in the mouse heart: evidence for isoform switching during heart development. J Mol Cell Cardiol 26:1449–1459PubMedCrossRefGoogle Scholar
  26. Johnson DE, Williams LT (1993) Structural and functional diversity in the FGF receptor multigene family growth factors and oncogenes. Adv Cancer Res 60:1–60PubMedCrossRefGoogle Scholar
  27. Jones PF (1997) Tied up (or down?) with angiopoietins. Angiogenesis 1(1):38–44PubMedCrossRefGoogle Scholar
  28. Knoepfler PS, Bloor CM, Carroll SM (1995) Urokinase plasminogen activator activity is increased in the myocardium during coronary artery occlusion. J Mol Cell Cardiol 27:1317–1324PubMedCrossRefGoogle Scholar
  29. Koblizek TI, Weis C, Yancpoulos GD, Deutsch U, Risau W (1998) Angiopoie-tin induces sprouting angiogenesis in-vitro. Curr Biol 8(N9):529–532PubMedCrossRefGoogle Scholar
  30. McNeil PL, Muthukrishnan WE, D’Amore PA (1989) Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 109:811–821PubMedCrossRefGoogle Scholar
  31. Mignatti P, Morimoto T, Rifkin DB (1992) Basic fibroblast growth factor, a protein devoid of of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151:81–93PubMedCrossRefGoogle Scholar
  32. Moscatelli D (1987) High and low affinity binding sites for basic fibroblast growth factor on cultured cells absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 131(1):123–130PubMedCrossRefGoogle Scholar
  33. Muthukrishan L, Warder E, McNeil PL (1991) Basic fibroblast growth factor is efficiently released from cytosolic storage sites through plasma membrane disruptions of endothelial cells. J Cell Physiol 148:1–16CrossRefGoogle Scholar
  34. Myers RL, Payson RA, Chotani MA, Deaven LL, Chiu IM (1993) Gene structure and differential expression of acidic fibroblast growth factor mRNA: identification and distribution of four different transcripts. Oncogene 8(2):341–349PubMedGoogle Scholar
  35. Nagamine Y, Sudol M, Reich E (1983) Hormonal regulation of plasminogen activator mRNA in porcine kidney cells. Cell 32(4): 1184–1190CrossRefGoogle Scholar
  36. Ny T, Ohlsson M, Strandberg L (1988) The gene for t-PA in tissue-type plasminogen activator (t-PA). In: Kluft C (ed) Physiological and clinical aspects. CRC Press, Boca RatonGoogle Scholar
  37. Opdenakker G, Ashino-Fuse H, Van Damme J, Billiau A, De Somer P (1983) Effects of 12-O-tetradecanoylphorbol 13-acetate on the production of mRNAs for human tissue-type plasminogen activator. Eur J Biochem 131:481–487PubMedCrossRefGoogle Scholar
  38. Ossowski L, Reich E (1983) Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611–619PubMedCrossRefGoogle Scholar
  39. Partanen J, Vainikka S, Korhonen J, Armstrong E, Alitalo K (1992) Diverse receptors for fibroblast growth factors. Prog Growth Factors Res 4(1):69–83CrossRefGoogle Scholar
  40. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359:845–848PubMedCrossRefGoogle Scholar
  41. Prats H, Kaghad M, Prats AC, Klagsbrun M, Lelias JM, Liauzun P, Chalon P, Tauber JP, Amalric F, Smith JA, Caput D (1989) High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG co-dons. Proc Natl Acad Sci USA 86:1836–1840PubMedCrossRefGoogle Scholar
  42. Salmivirta M, Heino J, Jalkanen M (1992) Basic fibroblast growth factor syn-decan complex at cell surface or immobilized to matrix promotes cell growth. J Biol Chem 267(25): 17606–17610PubMedGoogle Scholar
  43. Saunders S, Bernfield M (1988) Cell surface proteoglycan binds mouse mammary epithelial cells to fibronectin and behaves as a receptor for intestinal matrix. J Cell Biol 106(2):423–430PubMedCrossRefGoogle Scholar
  44. Schaper W, Schaper J (1993) Collateral circulation — heart, brain, kidney, limbs. Kluwer Academic, BostonCrossRefGoogle Scholar
  45. Schlessinger J, Ullrich A (1992) Growth factor signaling by receptor tyrosine kinases. Neuron 9:383–391PubMedCrossRefGoogle Scholar
  46. Schlessinger J, Lax I, Lemmon M (1995) Regulation of growth factor activation by proteoglycans: what is the role of the low affinity receptors? Cell 83:357–360PubMedCrossRefGoogle Scholar
  47. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845PubMedCrossRefGoogle Scholar
  48. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I (1994) Heparin-induced oli-gomerization of FGF molecules is responsible for FGF receptor dimeriza-tion, activation, and cell proliferation. Cell 79:1015–1024PubMedCrossRefGoogle Scholar
  49. Thomas KA (1996) Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271:603–606PubMedCrossRefGoogle Scholar
  50. Tudor RM, Flook BE, Voelkel NF (1995) Increased gene expression of VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic ischemia. J Clin Invest 95:1789–1807CrossRefGoogle Scholar
  51. Van Belle E, Witzenbichler B, Chen D, Silver M, Ling C, Isner JM (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. Circulation 97:381–390PubMedCrossRefGoogle Scholar
  52. Vassalli JD, Reich E (1977) Macrophage plasminogen activator: induction of products of activated lymphoid cells. J Exp Med 145:429–437PubMedCrossRefGoogle Scholar
  53. Vassalli JD, Dayer JM, Wohlwend A, Belin D (1984) Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med 159:1653–1668PubMedCrossRefGoogle Scholar
  54. Waltenberg J, Mayr U, Pentz S, Hombach V (1996) Functional upregulation of vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94(7): 1647–1654CrossRefGoogle Scholar
  55. Wang J-K, Gao G, Goldfarb M (1994) Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol Cell Biol 14(1): 181–188PubMedGoogle Scholar
  56. Williams JRB (1951) The fibrinolytic activity of urine. Br J Exp Pathol 32:530–537PubMedGoogle Scholar
  57. Woods A, Couchman R (1998) Syndecans: synergistic acitvators of cell adhesion. Trends Cell Biol 8:189–192PubMedCrossRefGoogle Scholar
  58. Xin X, Johnson AD, Scott-Burden T, Engler D, Casscells W (1994) The predominant form of fibroblast growth factor receptor expressed by proliferating human arterial smooth muscle cells in culture is type I. Biochem Bio-phys Res Commun 204(2):557–564CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • E. Deindl
  • W. Schaper

There are no affiliations available

Personalised recommendations